UnitedHealth stock holds Buy rating at UBS amid Medicare Advantage changes
PositiveFinancial Markets

UnitedHealth's stock has maintained a Buy rating from UBS, even as changes to Medicare Advantage are on the horizon. This is significant because it reflects investor confidence in UnitedHealth's ability to navigate potential challenges in the healthcare landscape, ensuring continued growth and stability for the company.
— Curated by the World Pulse Now AI Editorial System